Clinical Trial Update: Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse [Phase 1, Phase 2]

View source ↗

Summary

A single-arm Phase 1/2 clinical trial evaluating post-transplant azacitidine plus chidamide to prevent relapse in acute myeloid leukemia; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Chidamide (chidamide)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: RECRUITING